Fitchburg

Medical device manufacturer Arrhythmia Research Technology of Fitchburg drastically lowered its losses in the last quarter of 2013 and for all of the year and expects to return to profitability in 2014, the company said.

Three community development organizations in Central Massachusetts received a combined $330,000 to increase economic opportunities for low- and middle-income households, the Patrick administration announced today.

The state gaming commission has picked Plainville over Leominster and Raynham for the one slots parlor license mandated in the 2011 gambling expansion law.

Four life science companies in Central Massachusetts received a combined $1.54 million in tax incentives to create 87 jobs in 2014, the Massachusetts Life Sciences Center (MLSC) announced Wednesday.

Unitil Corp., which provides power to business and residential customers in Ashby, Fitchburg, Lunenburg and Townsend, reported earnings of $21.6 million for the year, and $10.3 million for the fourth quarter which ended Dec. 31, representing respective increases of $3.5 million and $1.3 million.

Lowell-based Enterprise Bancorp Inc., which has branches in Acton, Fitchburg, Leominster and Westford, reported annual net income of $13.5 million for 2013, a 9-percent increase over 2012, in a milestone year for loan growth, according to an earnings statement.

Manufacturers based in North Central Massachusetts will now have new access to renewable electricity, thanks to a new contract between the North Central Massachusetts Development Corp. (NCMDC) and Nugen Capital Management LLC to generate net metering credits from a new solar facility to be built in Lunenburg.

Fitchburg-based Arrhythmia Research Technology Inc. announced the closing of its offering of notes and warrants to purchase $500,000 in common stock.

An expert in business revitalization will become Fitchburg's director of economic development and chief marketing officer next week.

Arrhythmia Research Technology of Fitchburg saw a 4.7 percent drop in revenue for the third quarter, but substantially cut its losses as the medical device manufacturer touted several victories from July through September, the company said today.